About US
Contact us
-
Roche to acquire majority stake in Foundation Medicine for $1.3bnSwiss drugmaker Roche is set to invest $1.3bn to acquire a 56.3% stake in US-based Foundation Medicine (FMI), in a bid to expand treatment options for cancer patients. Roche will tender 15.6 million2015/1/23
-
GSK Consumer to acquire Novartis OTC business in India for $17mNovartis India has approved transfer of its over-the-counter division (OTC) division to GlaxoSmithKline Consumer (GSK CPL), for Rs1.97bn ($17.6m). GSK CPL is a consumer healthcare joint venture (JV)2015/1/19
-
Armed with Pegasus win, AstraZeneca targets another sales boost for BrilintaSoon after CEO Pascal Soriot took over at AstraZeneca ($AZN) in 2012, he declaredBrilintato be a big opportunity for growth. That was a surprise, given the blood thinner's laggardly sales since its 202015/1/15
-
UPDATED: JPM: Glaxo ready to shift off Advair; BMS isn't afraid of Merck; Roche eyes combos and M&ASAN FRANCISCO--Here's a game to play at the annual JP Morgan Healthcare Conference. Attend presentations by executives at Big Pharma, Big Biotech, and slightly less big biopharma companies, hoping to2015/1/15
-
Roche bets $1.2B on Foundation Medicine with deal for majority stakeRoche ($RHHBY) is throwing the full weight of its global rep and more than $1 billion behind Foundation Medicine's ($FMI) ambitious sequencing technology, designed to tailor cancer treatments to parti2015/1/13
-
Is once-skeptical J&J coming around on pharma's breakup craze?SAN FRANCISCO--Johnson & Johnson ($JNJ) has been pretty quiet over the past couple of years as it's watched its Big Pharma peers slim down like there's no tomorrow. But now, it seems the pharma gi2015/1/13
-
Bayer shuffles agency assignments to fold in Merck OTC brandsBayer, gunning for the global consumer health lead, said over the summer that it's intent on keeping all the OTC brands it picked up in its $14.2 billion deal for Merck's ($MRK) unit. But in order for2015/1/12
-
Roche builds CLL case for Gazyva in two-horse race with GSKRoche ($RHHBY) wonFDAapproval for a supplemental license application of its chronic lymphocytic leukemia (CLL) drugGazyva, strengthening its case over rival GlaxoSmithKline ($GSK) and adding some ammo2015/1/12
-
FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain managementHospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administrat2015/1/10
-
Tikcro enters into research and license agreement with YedaTikcro Technologies Ltd. (OTC PK: TIKRF) today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the W2015/1/9